Physician profile
Olesya Grinenko
NPI 1306345210
$3,132.14
in general payments reported to CMS, 2019-2025
8 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.90 · 2020: $122 · 2022: $2,707 · 2024: $62.28 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dixi Medical USA Corp | $2,707.47 | 2022 | |
| Sk Life Science, INC. | $121.92 | 2020 | |
| Abbvie INC. | $113.68 | 2024-2025 | |
| Biogen, INC. | $80.45 | 2024-2025 | Vumerity, Tysabri |
| Livanova USA, INC. | $48.39 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $22.67 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $20.33 | 2024 | |
| Supernus Pharmaceuticals, INC. | $17.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olesya Grinenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.